Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 2
1994 3
1995 1
1996 2
1997 5
1998 1
1999 1
2000 1
2001 1
2002 1
2003 1
2007 1
2012 1
2016 3
2017 2
2018 5
2019 4
2021 6
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
Accès précoce aux produits de santé en France : des avancées majeures du CSIS (Conseil stratégique des industries de santé) à concrétiser (modalités, réglementations, financements).
Albin N, Chassagnol F, Bergmann JF; Les participants à la table ronde « Aspects organisationnels et réglementaires » des Ateliers de Giens XXXIV; avec la collaboration de. Albin N, et al. Therapie. 2019 Feb;74(1):87-101. doi: 10.1016/j.therap.2018.11.009. Epub 2018 Dec 6. Therapie. 2019. PMID: 30612729 French. No abstract available.
How to strengthen the presence of patients in health technology assessments conducted by the health authorities.
Mamzer MF, Dubois S, Saout C; participants of Round Table «Topical Subject» of Giens XXXIII, Albin N, Béhier JM, Buisson A, Diebolt V, Delaitre O, Duguet C, Fagon JY, Gaillard S, Le Jeunne C, Mazars R, Micallef J, Nabarette H, Piazza L, Raynaud C, Varoqueaux N. Mamzer MF, et al. Among authors: albin n. Therapie. 2018 Feb;73(1):95-105. doi: 10.1016/j.therap.2017.11.004. Epub 2017 Dec 21. Therapie. 2018. PMID: 29478707 French.
Idelalisib-related pneumonitis.
Haustraete E, Obert J, Diab S, Abbes S, Zini JM, Valade S, Lerolle N, Albin N, Arnulf B, Bouaziz JD, Hussenet C, Tazi A, Bergeron A. Haustraete E, et al. Among authors: albin n. Eur Respir J. 2016 Apr;47(4):1280-3. doi: 10.1183/13993003.01670-2015. Epub 2016 Feb 25. Eur Respir J. 2016. PMID: 26917607 Free article. No abstract available.
Evaluation of Clinical Trials in Onco-haematology: A New Method Based on Risk Analysis and Multidisciplinarity.
Lapière J, Christen C, Kerouani-Lafaye G, Monard A, Turcry F, Grude F, Gazin V, Burbank M, Chocarne P, Taleb A, Belgodere L, Brunel L, Chu C, Deligny C, Ake E, Gonçalves S, Bouheret P, Barbou-des-Courières S, Sainte-Marie I, Guyader G, Boudali L, Albin N. Lapière J, et al. Among authors: albin n. Ther Innov Regul Sci. 2021 May;55(3):601-611. doi: 10.1007/s43441-020-00256-7. Epub 2021 Jan 27. Ther Innov Regul Sci. 2021. PMID: 33502745
Maximizing algebraic connectivity in interconnected networks.
Shakeri H, Albin N, Darabi Sahneh F, Poggi-Corradini P, Scoglio C. Shakeri H, et al. Among authors: albin n. Phys Rev E. 2016 Mar;93(3):030301. doi: 10.1103/PhysRevE.93.030301. Epub 2016 Mar 21. Phys Rev E. 2016. PMID: 27078276 Free article.
Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé).
Vignot S, Daynes P, Bacon T, Vial T, Montagne O, Albin N, Emmerich J, Ratignier-Carbonneil C, Martin D, Maison P. Vignot S, et al. Among authors: albin n. Front Pharmacol. 2021 Apr 28;12:635841. doi: 10.3389/fphar.2021.635841. eCollection 2021. Front Pharmacol. 2021. PMID: 33995037 Free PMC article. No abstract available.
41 results